Skip to main content
. 2021 Mar 15;14(5):962–974. doi: 10.1007/s12265-021-10112-0

Table 1.

Baseline characteristics of all the study participants (n=15 in total) administered ISDN

Isosorbide dinitrate
(15)
Male sex 12 (80)
Age, years 66±14
Height, cm 170±7
BMI kg/m2 28.5±3.2
Previous PCI 9 (60)
Previous MI 5 (33.3)
LVEF, % 57 (51 to 63)
Diabetes mellitus 5 (33.3)
Hypertension 10 (66.7)
Hypercholesterolemia 13 (86.7)
Family history 7 (46.7)
Smoking history 11 (73.3)
Current medications
Βeta-blocker 10 (66.7)
Long-acting nitrate 6 (40)
Statin 12 (80)
ACEi/AIIRB 10 (66.7)
Ca channel antagonist 4 (26.7)
Nicorandil 1 (6.7)
Aspirin 14 (93.3)
Clopidogrel 14 (93.3)
Procedural details
Diseased vessels 1 (1 to 2)
LAD/Cx/RCA 13/1/2
Duration mins 76 (64 to 91)

Normally distributed continuous data are displayed as mean ± SD, continuous data that are not normally distributed are presented as median (IQR), and categorical data are presented as n (%), where n is the number of patients in that study group with a certain characteristic. * Indicates P value<0.05. BMI body mass index, PCI percutaneous coronary intervention, MI myocardial infarction, LVEF left ventricular ejection fraction, ACEi angiotensin converting enzyme inhibitor, AIIRB angiotensin II receptor blocker, Pd/Pa mean distal coronary pressure/man aortic pressure, LAD left anterior descending artery, Cx circumflex artery, RCA right coronary artery